Born out of necessity
Our founder lived through drug shortages firsthand, then spent years in academic research developing the models behind the AIM platform, which is now used to optimize medicine production at scale. Read our story
Production Acceleration for GMP Manufacturing
AIM finds the capacity your plant already has and turns it into a schedule the floor can run today.
"AIM unlocked 20% of capacity on our bottleneck equipment without capital investment, letting us take on new volumes without adding a single line."
Head of Site, Leading Global CDMO (Top 5)
Built for CDMOs & integrated pharma sites running GMP production
Each drug modality has its own production rules. How those rules interact is what makes capacity loss nearly impossible to see, let alone recover. AIM models the constraints that drive time-to-market and keeps finding capacity as conditions shift. When a deviation hits, recovery is fast enough that you don't lose the shift.
Doses Deployed through AIM:10,574,410
45-65%
Typical OEE in GMP pharma manufacturing, against an 85% world-class benchmark
20%
Capacity recovered on bottleneck equipment, no added capex
<90 days
To turn found capacity into running production
The AIM Platform
AI-native platform that finds, activates, and accelerates the capacity your plant already has.
01
Capacity Finder
Uncovers capacity already sitting in your equipment windows and operator hours.
02
Production Activation
Turns that capacity into usable production hours through flexible, managed scheduling.
03
Production Acceleration
Monitors in real time and recommends the recovery path when deviations halt production.
Built by the people who've studied this problem, and lived it
A pipeline of features, not drugs
AIM's roadmap is grounded in operational excellence, lean methodology, and industrial engineering. No therapeutics involved.
Continuous improvement at its core
Every model is shaped alongside the operators, planners, and site heads who have to trust it on a live shift. Every feature shipped is aligned with accelerating medicine production capacity and stabilizing it.